Page last updated: 2024-08-24

4-propionyloxy-4-phenyl-n-methylpiperidine and cyclosporine

4-propionyloxy-4-phenyl-n-methylpiperidine has been researched along with cyclosporine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabot, MC; Cao, Ht; Geffen, V; Giuliano, AE; Han, TY; Lavie, Y; Lucci, A; Volner, A1
Behnam-Motlagh, P; Brännström, T; Grankvist, K; Gudey, SK; Johansson, A; Karlsson, T; Tyler, A1

Other Studies

2 other study(ies) available for 4-propionyloxy-4-phenyl-n-methylpiperidine and cyclosporine

ArticleYear
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    The Journal of biological chemistry, 1997, Jan-17, Volume: 272, Issue:3

    Topics: Ceramides; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycosphingolipids; Glycosylation; Humans; Meperidine; Tamoxifen; Tumor Cells, Cultured; Verapamil

1997
Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Experimental cell research, 2015, Aug-01, Volume: 336, Issue:1

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Cell Proliferation; Ceramides; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Glucosyltransferases; Humans; Immunosuppressive Agents; Lung Neoplasms; Meperidine; Mesothelioma; Mesothelioma, Malignant; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Trihexosylceramides; Tumor Cells, Cultured

2015